Vimarsana
Biggest News Aggregation in the World

Page 35 - Fda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approval Today - Breaking & Trending Today

FDA Approves Second Over-the-Counter Naloxone Nasal Spray Product - Vimarsana News

FDA Approves Second Over-the-Counter Naloxone Nasal Spray Product

/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC),...

EpiBone to Start Clinical Trials for Knee Cartilage Grown in Lab - Vimarsana News

EpiBone to Start Clinical Trials for Knee Cartilage Grown in Lab

/PRNewswire/ -- EpiBone has received Investigational New Drug (IND) clearance from the FDA to begin testing its lab-grown knee cartilage in humans. The...

Have mushrooms growing in your yard? Boston doctor says be careful - Vimarsana News

Have mushrooms growing in your yard? Boston doctor says be careful

Dr. Ali Raja, of Mass General, also talks about the FDA's approval of a new drug to protect babies and toddlers from RSV.

Source: wcvb.com
Here's when OTC birth control pill will be available in Mass. - Vimarsana News

Here's when OTC birth control pill will be available in Mass.

The FDA cleared once-a-day Opill to be sold without a prescription, making it the first such medication to be moved out from behind the pharmacy counter.

Source: wcvb.com
Dr Matous on Barriers to CAR T-Cell Therapy Administration in Multiple Myeloma - Vimarsana News

Dr Matous on Barriers to CAR T-Cell Therapy Administration in Multiple Myeloma

Jeffrey V. Matous, MD, discusses potential strategies to overcome barriers to receiving CAR T-cell therapy for patients with multiple myeloma, and how the potential use of these agents in earlier lines could improve infusion wait times and rates of disease progression.